Candel Therapeutics
Price & Volume
Stats
See more52W Range | $3.78-$13.68 |
Market Cap | $289.2M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $31,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$20M |
Diluted EPS | -$0.66 |
News
See moreYahoo Finance • 11 days ago
Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
Yahoo Finance • 24 days ago
Erasca, Candle, Xencor drop as BofA downgrades on lack of near-term catalysts
Yahoo Finance • 26 days ago
Candel Therapeutics Appoints Renowned Immunotherapy Pioneer Carl H. June, M.D., to Research Advisory Board
Yahoo Finance • last month
Candel Therapeutics to Participate in Upcoming Investor Conferences in September
About
CEO | Dr. Paul-Peter Tak FOCIS, M.D., Ph.D. |
CFO | Mr. Charles Schoch |
Address | 117 Kendrick Street, Needham, MA, United States, 02494 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 38 |
